DSP Healthcare Fund Direct Growth
DSP Healthcare Fund Direct Growth

DSP Healthcare Fund Direct Growth

Compare
Equity
Direct
Sector - Healthcare

NAV: ₹ 23.7 as on 25-11-2022

Fund Performance
zero opening, trading, fund transfer fee
1075 people have invested ₹ 36L in mutual fund in the last three months

INDmoney Rank

Powered by IND quant engine
IND ranking is not available for this fund.
Pros
3Y returns in the top 25% of the category
Cons
No bad points found for this fund.

Fund Performance

Return
1M
3M
6M
1Y
3Y
This Fund
3.5%
9.8%
12.7%
0.3%
29.5%
Benchmark
3.2%
3.8%
13.4%
6.9%
16.8%
Category
0.2%
4.4%
7.9%
-4.1%
23%
About the Fund

DSP Healthcare Fund Direct Growth is an equity fund. This fund was started on  30 November, 2018. The fund is managed by Jay Kothari, Chirag Dagli, Vinit Sambre. The fund could potentially beat inflation in the long-run.

Key parameters

1) DSP Healthcare Fund Direct Growth has a NAV of 23.749 as on 25-11-2022.

2) DSP Healthcare Fund Direct Growth has 1219 Cr worth of assets under management (AUM) as on 30-09-2022 and is less than category average.

3) The fund has an expense ratio 0.81 %.

Fund Overview

Expense ratio
Expense ratio
0.81%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹1219 Cr
Inception Date
Inception Date
30 November, 2018
Min Lumpsum/SIP
Min Lumpsum/SIP
₹500/₹500
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
19.87%

Fund Distribution

  • Equity 98.3%
  • Debt & Cash 1.7%
Size breakup
Large cap
47.7%
Mid cap
28.7%
Small cap
21.9%

Sector Allocation

Oct'22

Sep'22

Aug'22

Health

97.6%

Financial Services

2.4%

Top Holdings

  • All
  • Equity
  • Debt & Cash
Total Holdings26
Equity Holdings25
Debt Holdings1

What changed

in last one month
  • Scheme
  • Portfolio
AUM increased by 41.5 Cr in last 1M
Oct'22 return underperformed benchmark

Change in AUM

Oct'22
₹ 1.2K Cr
Sep'22
₹ 1.2K Cr
Aug'22
₹ 1.2K Cr

Fund Returns vs Benchmark

Oct'22
3.85%
5.37%
Sep'22
3.35%
-2.51%
Aug'22
-1.08%
3.22%
Fund Return
Benchmark Return

Concentration Analysis

Fund
Oct'22
Oct'22
Aug'22
No of Holdings
26
25
26
Top 5 Company Concentration
44.6%
46%
46.5%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (16.6%)
Sun Pharmaceuticals Industries Ltd (16.1%)
Sun Pharmaceuticals Industries Ltd (15.3%)
No of Sectors
3
3
3
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (96%)
Health (96.3%)
Health (97%)

Fund Manager

Jay Kothari

Jay Kothari

Managing this fund since 30 November 2018

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
DSP Small Cap Fund Direct Plan Growth
30.89%
30.94%
DSP Midcap Fund Direct Plan Growth
17%
23.14%
DSP Equity Opportunities Fund Direct Plan Growth
17.81%
18.25%
Chirag Dagli

Chirag Dagli

Managing this fund since 1 December 2020

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
DSP Healthcare Fund Direct Growth
29.47%
23%
Vinit Sambre

Vinit Sambre

Managing this fund since 30 November 2018

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
DSP Focus Fund Direct Plan Growth
11.17%
16.38%
DSP Small Cap Fund Direct Plan Growth
30.89%
30.94%
DSP Midcap Fund Direct Plan Growth
17%
23.14%

AMC details

Address
Tulsiani Chambers,,West Wing, 11th Floor,,Nariman Point
Phone
91-22-66578000
Fund House
DSP Investment Managers Private Limited

Fund Highlights

meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 24.23% since inception which is more than its category average return of 17.91%
Fund Allocations

Fund Allocations

This fund has an allocation of 98.32% in Equity, 0% in Debt and 1.68% in Cash related instruments
AUM size ₹1219 Cr

AUM size ₹1219 Cr

This fund has AUM of ₹1219 Cr which is less than its category average of ₹ 1367 Cr
Expense Ratio 0.81%

Expense Ratio 0.81%

This fund has an expense ratio of 0.81% which is less than its category average expense ratio of 1.52%

Frequently Asked Questions

The current NAV of DSP Healthcare Fund Direct Growth is 23.75.
Existing (Absolute + CAGR)
DSP Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
3.47%
3.47%
6 Month Returns
12.67%
12.67%
1 Year Returns
0.27%
0.27%
3 Years Returns
117%
29.47%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.81 as on October 2022
1219 Cr as on October 2022
Sun Pharmaceuticals Industries Ltd(16.63%),Cipla Ltd(9.92%),Apollo Hospitals Enterprise Ltd(6.9%),Ipca Laboratories Ltd(5.86%),Procter & Gamble Health Ltd(5.25%) as on October 2022
Health(96%),Financial Services(2.32%),Cash Equivalent(1.68%) as on October 2022
The alpha ratio for the DSP Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
DSP Healthcare Fund Direct Growth
2.04
9.03
-
As on month end.
The alpha for DSP Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the DSP Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
DSP Healthcare Fund Direct Growth
1
0.78
-
As on month end.
The Beta for DSP Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the DSP Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
DSP Healthcare Fund Direct Growth
-0.32
1.27
-
As on month end.
The sharpe ratio for DSP Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the DSP Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
DSP Healthcare Fund Direct Growth
16.05
18.61
-
As on month end.
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
2.54
0.81
Jay Kothari,Chirag Dagli,Vinit Sambre are the fund managers of DSP Healthcare Fund Direct Growth
The Exit load of DSP Healthcare Fund Direct Growth is 1%

Mutual Fund execution provided by

Technology facilitation Services provided by Finzoom Investment Advisors Pvt. Ltd. - Advisory unit. SEBI Registered Investment Advisor: INA100012190 | BASL Registration No. 1154 | BSE StarMF Platform code: 24801

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future returns.